ONCOLOGY_HEADER

MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED

WE ARE NOW NSE LISTED!

Medicamen Biotech Limited is now NSE LISTED

ONCOLOGY_HEADER

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

Poised to launch novel oncology products

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

ONCOLOGY_HEADER

Haridwar Unit 1 for formulations is WHO GMP approved

WHO GMP approved

Haridwar Unit 1 for formulations is WHO GMP approved

ONCOLOGY_HEADER

ANDA filing for oncology formulations in process

Abbreviated New Drug Application (ANDA) filing process

ANDA filing for oncology formulations in process

MBl-_LOGO1A

Infrastructure & Research

API Facility

Corporate R&D

Contact Info

Address Details

1506, Chiranjiv Tower, 43 Nehru Place, New Delhi - 110019 (India)

+91-11-47589500,
info@medicamen.com

Daily: 9:00 am - 6:00 pm
Sunday: Closed

Copyright 2018 MEDICAMEN BIOTECH LIMITED ©  All Rights Reserved